Etidronate is a first-generation bisphosphonate drug primarily used to treat Paget's disease of bone, manage osteoporosis, and prevent heterotopic ossification. It functions by inhibiting osteoclast-mediated… Read more
Etidronate is a first-generation bisphosphonate drug primarily used to treat Paget's disease of bone, manage osteoporosis, and prevent heterotopic ossification. It functions by inhibiting osteoclast-mediated bone resorption, thereby slowing the breakdown of bone and helping to regulate bone metabolism. This category includes high-quality reference standards for Etidronate API, alongside its identified impurities, metabolites, and stable isotope labelled compounds. These materials are essential for pharmaceutical laboratories conducting rigorous analytical testing, impurity profiling, and method validation. By providing consistent reference materials, researchers can ensure the accuracy of quantitative analyses, such as those performed via mass spectrometry, and maintain strict quality control standards throughout the drug development lifecycle. The inclusion of stable isotope labelled standards further facilitates precise tracking and reliable quantification, supporting compliance with regulatory guidelines for safety and purity in pharmaceutical products.